A share price of Cg Oncology Inc [CGON] is currently trading at $30.94, up 7.92%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CGON shares have gain 16.84% over the last week, with a monthly amount glided 14.85%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on August 19, 2025, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $55. On May 02, 2025, JP Morgan initiated with a Overweight rating and assigned a price target of $41 on the stock. Scotiabank started tracking the stock assigning a Sector Perform rating and suggested a price target of $23 on April 16, 2025. TD Cowen initiated its recommendation with a Buy. UBS started tracking with a Buy rating for this stock on October 24, 2024, and assigned it a price target of $60. In a note dated September 23, 2024, RBC Capital Mkts initiated an Outperform rating and provided a target price of $66 on this stock.
Cg Oncology Inc experienced fluctuations in its stock price throughout the past year between $14.80 and $40.47. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $30.94 at the most recent close of the market. An investor can expect a potential return of 77.76% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Trailing Twelve Months sales for Cg Oncology Inc [NASDAQ:CGON] were 0.55M which represents -100.00% decline. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at -285.46%, Pretax Profit Margin comes in at -232.45%, and Net Profit Margin reading is -157.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.13 and Total Capital is -0.23. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 28.86 points at the first support level, and at 26.78 for the second support level. However, for the 1st resistance point, the stock is sitting at 32.49, and for the 2nd resistance point, it is at 34.03.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cg Oncology Inc [NASDAQ:CGON] is 22.15. Further, the Quick Ratio stands at 22.15, while the Cash Ratio is 0.48. Considering the valuation of this stock, the price to sales ratio is 4289.28, the price to book ratio is 3.52.
Transactions by insiders
Recent insider trading involved Song Hong Fang, Director, that happened on Sep 03 ’25 when 100000.0 shares were sold. Director, POST LEONARD E completed a deal on Sep 03 ’25 to sell 1000.0 shares. Meanwhile, Director Charming Jade Ltd bought 100000.0 shares on Sep 03 ’25.
